Increased levels of extracellular amyloid-β (Aβ) peptide in neuritic plaques and intracellular fibrillar aggregates of phosphorylated tau are pathological hallmarks of AD in brain tissues, in addition to the widespread loss of neurons and synapses [2]. This evidence concerns the gene MAPT and Alzheimer disease.